Autism Spectrum Disorder (ASD) is endowed with impressive heritability estimates and high recurrence rates; its genetic underpinnings are very heterogeneous and include many common and rare variants. Array-comparative genomic hybridization (CGH) offers significant sensitivity for the identification of copy number variations (CNVs) which can be a susceptibility factor for ASD. The aim of this study was to evaluated diagnostic yield and clinical impact of chromosomal microarray analysis in ASD. We performed Array-CGH for 329 ASD patients; four authors in accordance with the American College of Medical Genetics and Genomics recommendation blindly classified outcomes. After, patients were reassessed, further medical testing derived from the outcome of array-CGH was requested. Pathogenic/likely pathogenic CNV were identified in about 15.2% of patients and in about 27.1% were detected as possibly causal. Among patients with pathogenic/likely pathogenic CNV, in 52.0% the outcome of the array-CGH led to request other diagnostic tests that would not otherwise have been performed. From the results received to date, we have positive outcomes in the 55.0% of the exams. The results of our study highlighting the relevance of array-CGH in the genetic of diagnosis and underlie how its clinical translation can improve the care of children with ASD.

ARRAY-CGH nei Disturbi di Spettro Autistico: ricaduta diagnostica e impatto sulla pratica clinica

CUCINOTTA, Francesca
2021-02-04

Abstract

Autism Spectrum Disorder (ASD) is endowed with impressive heritability estimates and high recurrence rates; its genetic underpinnings are very heterogeneous and include many common and rare variants. Array-comparative genomic hybridization (CGH) offers significant sensitivity for the identification of copy number variations (CNVs) which can be a susceptibility factor for ASD. The aim of this study was to evaluated diagnostic yield and clinical impact of chromosomal microarray analysis in ASD. We performed Array-CGH for 329 ASD patients; four authors in accordance with the American College of Medical Genetics and Genomics recommendation blindly classified outcomes. After, patients were reassessed, further medical testing derived from the outcome of array-CGH was requested. Pathogenic/likely pathogenic CNV were identified in about 15.2% of patients and in about 27.1% were detected as possibly causal. Among patients with pathogenic/likely pathogenic CNV, in 52.0% the outcome of the array-CGH led to request other diagnostic tests that would not otherwise have been performed. From the results received to date, we have positive outcomes in the 55.0% of the exams. The results of our study highlighting the relevance of array-CGH in the genetic of diagnosis and underlie how its clinical translation can improve the care of children with ASD.
4-feb-2021
autism spectrum disorder, array Comparative Genomic Hybridization, copy number variants, Genotype-phenotype correlation.
File in questo prodotto:
File Dimensione Formato  
Tesi dottorato Cucinotta.pdf

accesso aperto

Descrizione: tesi
Tipologia: Tesi di dottorato
Licenza: Creative commons
Dimensione 1.63 MB
Formato Adobe PDF
1.63 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3221420
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact